Stonebridge Financial Group LLC Buys New Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stonebridge Financial Group LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, HoldingsChannel reports. The fund purchased 658 shares of the medical equipment provider’s stock, valued at approximately $343,000.

Other institutional investors have also bought and sold shares of the company. Focus Financial Network Inc. raised its position in shares of Intuitive Surgical by 17.1% during the 4th quarter. Focus Financial Network Inc. now owns 1,491 shares of the medical equipment provider’s stock valued at $778,000 after buying an additional 218 shares in the last quarter. Summit Trail Advisors LLC grew its position in Intuitive Surgical by 21.1% in the fourth quarter. Summit Trail Advisors LLC now owns 6,602 shares of the medical equipment provider’s stock worth $3,446,000 after acquiring an additional 1,150 shares in the last quarter. Sycomore Asset Management increased its stake in Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares during the last quarter. Soltis Investment Advisors LLC raised its position in Intuitive Surgical by 12.1% during the fourth quarter. Soltis Investment Advisors LLC now owns 582 shares of the medical equipment provider’s stock valued at $304,000 after purchasing an additional 63 shares during the period. Finally, Silicon Valley Capital Partners bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $129,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $591.65 on Wednesday. The stock has a market cap of $210.73 billion, a price-to-earnings ratio of 92.30, a PEG ratio of 5.67 and a beta of 1.39. The firm’s 50-day moving average is $555.91 and its two-hundred day moving average is $515.92. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,348 shares of company stock valued at $3,587,582. Company insiders own 0.80% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on ISRG. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Jefferies Financial Group boosted their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Mizuho raised their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Royal Bank of Canada raised their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.